Organovo Holdings, Inc.
ONVO
株式のランク
#36086
Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering... Organovo Holdings, Inc. is a biotechnology firm that specializes in engineering sophisticated 3D tissues designed to accurately mimic critical facets of human diseases. Central to its operations is a comprehensive 3D human tissue platform, which features the company's proprietary NovoGen Bioprinters. These automated devices are crucial for fabricating complex, living 3D tissues from mammalian cells. The platform also includes supporting technologies necessary for creating specialized "bio-inks" and for the bioprinting of multi-cellular tissues with intricate structures. Organovo supplies specific products, such as ExVive human liver tissue and ExVive human kidney tissue, which are employed for predictive preclinical evaluation of investigational drug compounds. The company was founded in 2007 and maintains its corporate headquarters in Solana Beach, California.
株価
$2.00
最終同期: 2025-05-19
時価総額
$2.93M
変化（1日）
-3.38%
変化（1年）
656.14%
国
US
取引 Organovo Holdings, Inc. (ONVO)
カテゴリー
Healthcare
の時価総額 Organovo Holdings, Inc.(ONVO)
時価総額: $2.93M
October 2026時点で、Organovo Holdings, Inc. の時価総額は $2.93M です。これは、当社のデータによると、Organovo Holdings, Inc. が世界で36086th番目に価値のある企業であることを意味します。時価総額は、上場企業の発行済株式の総市場価値であり、企業の価値を測るためによく使用されます。
Organovo Holdings, Inc. の時価総額の履歴（2014 から 2026 まで）
